KR20150036742A - 치료 화합물 - Google Patents

치료 화합물 Download PDF

Info

Publication number
KR20150036742A
KR20150036742A KR1020157004582A KR20157004582A KR20150036742A KR 20150036742 A KR20150036742 A KR 20150036742A KR 1020157004582 A KR1020157004582 A KR 1020157004582A KR 20157004582 A KR20157004582 A KR 20157004582A KR 20150036742 A KR20150036742 A KR 20150036742A
Authority
KR
South Korea
Prior art keywords
alkyl
cycloalkyl
halo
compound
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020157004582A
Other languages
English (en)
Korean (ko)
Inventor
젠동 진
레이 첸
Original Assignee
유니버시티 오브 아이오와 리써치 파운데이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 유니버시티 오브 아이오와 리써치 파운데이션 filed Critical 유니버시티 오브 아이오와 리써치 파운데이션
Publication of KR20150036742A publication Critical patent/KR20150036742A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C07F7/1872—Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/22—Tin compounds
    • C07F7/2208—Compounds having tin linked only to carbon, hydrogen and/or halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1020157004582A 2012-07-25 2013-07-25 치료 화합물 Withdrawn KR20150036742A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261675665P 2012-07-25 2012-07-25
US61/675,665 2012-07-25
US201261720785P 2012-10-31 2012-10-31
US61/720,785 2012-10-31
PCT/US2013/052081 WO2014018765A1 (en) 2012-07-25 2013-07-25 Therapeutic compounds

Publications (1)

Publication Number Publication Date
KR20150036742A true KR20150036742A (ko) 2015-04-07

Family

ID=49997838

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157004582A Withdrawn KR20150036742A (ko) 2012-07-25 2013-07-25 치료 화합물

Country Status (12)

Country Link
US (1) US9346781B2 (enExample)
EP (1) EP2877172A4 (enExample)
JP (1) JP6289463B2 (enExample)
KR (1) KR20150036742A (enExample)
CN (1) CN104812386A (enExample)
AU (1) AU2013295723A1 (enExample)
BR (1) BR112015001515A2 (enExample)
CA (1) CA2879908A1 (enExample)
IL (1) IL236873A0 (enExample)
IN (1) IN2015KN00386A (enExample)
MX (1) MX2015001134A (enExample)
WO (1) WO2014018765A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025231146A1 (en) * 2024-04-30 2025-11-06 University Of Iowa Research Foundation Synthetic superstolides and therapeutic use thereof

Also Published As

Publication number Publication date
US9346781B2 (en) 2016-05-24
IL236873A0 (en) 2015-03-31
EP2877172A4 (en) 2016-06-15
JP2015524809A (ja) 2015-08-27
EP2877172A1 (en) 2015-06-03
US20150210664A1 (en) 2015-07-30
MX2015001134A (es) 2015-10-12
WO2014018765A1 (en) 2014-01-30
CA2879908A1 (en) 2014-01-30
AU2013295723A1 (en) 2015-02-26
JP6289463B2 (ja) 2018-03-07
IN2015KN00386A (enExample) 2015-07-10
BR112015001515A2 (pt) 2017-07-04
CN104812386A (zh) 2015-07-29

Similar Documents

Publication Publication Date Title
JP2012509351A (ja) 有機化合物のフッ素化
Schwartz et al. Host-guest complexation. 65. Six new saddle shaped hosts based on fused dibenzofuran units
JP2000515552A (ja) 抗腫瘍アシルフルベンの全合成
CN107501287B (zh) Myrtuco mmulone J和Myrtucommuacetalone及其类似物的制备方法
Pietruszka et al. Diastereo‐and Enantiomerically Pure Allylboronates: Their Synthesis and Scope
FI93116B (fi) Stereospesifinen menetelmä furo/3,4-c/pyridiini-enantiomeerien valmistamiseksi
Marshall et al. Stereoselective total synthesis of (.+-.)-aristolactone and (.+-.)-epiaristolactone via [2, 3] Wittig ring contraction
JP7748736B2 (ja) 安定な新規芳香族ボロン酸エステル
EP2933246B1 (en) Versatile and functionalised intermediates for the synthesis of vitamin d and novel vitamin d derivatives
JP2006290871A (ja) 抗癌性を示す化合物およびその中間体ならびにそれらの製造方法
EP2831063B1 (en) Schweinfurthin analogues
US9346781B2 (en) Therapeutic compounds
RU2478630C2 (ru) Промежуточные соединения и способы получения зеараленоновых макролидных аналогов
JP2011526297A (ja) シュワインフルチンアナログ
JP4345311B2 (ja) 抗酸化剤
EP1004579A1 (de) Verfahren zur Herstellung von 2,3-Dihydroindolen (Indolinen), neuartige 2,3-Dihydroindole sowie deren Verwendung
CN110483289A (zh) 一种不对称合成手性烯酸酯的方法
CN110088094A (zh) 制备立体异构纯c9-缩醛的方法
JP2004307420A (ja) 細胞死抑制作用を有する化合物、およびその製造方法
Gorman Transition metal-mediated cyclizations and synthesis of annonaceous acetogenin analogs
JP2004315373A (ja) 抗腫瘍活性および血管新生阻害活性を有する化合物、ならびにその製造方法
US8822696B2 (en) Ligand for asymmetric synthesis catalyst, and process for production of alpha-alkenyl cyclic compound using the same
JP4171345B2 (ja) ラブデン酸の製造方法
JP4523761B2 (ja) 抗腫瘍活性を有する新規化合物、およびその製造方法
KR20130106908A (ko) 말론산 에스터와 오르쏘-히드록시아로마틱 알파,베타-불포화 알데히드를 사용한 4번 위치가 치환된 키랄 크로만올의 제조방법

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20150224

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid